cb-010,fludarabine,cyclophosphamide
Caribou Biosciences
['hodgkin', 'nhl', 'lymphoma']
data from antler presented during the 2022 eha congress show initial findings of cb-010 in patients with relapsed or refractory b-cell non-hodgkin lymphoma. #nhl #eha22 
Oncology news and insights from leading researchers and cancer centers.